ZRANB3 and cancer: To address this question, we analysed the correlation between ZRANB3 and TP53 expression across all TCGA cancer types considering (i) the TP53 status, wt or mutated, and (ii) its association with cell proliferation as function of MKI-67 expression, which also becomes downregulated by p53 [96].